182 related articles for article (PubMed ID: 21788602)
1. Differential impacts of blood pressure and lipid lowering on regression of ventricular and arterial mass: the Stop Atherosclerosis in Native Diabetics Trial.
Roman MJ; Howard BV; Howard WJ; Mete M; Fleg JL; Lee ET; Devereux RB
Hypertension; 2011 Sep; 58(3):367-71. PubMed ID: 21788602
[TBL] [Abstract][Full Text] [Related]
2. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.
Howard BV; Roman MJ; Devereux RB; Fleg JL; Galloway JM; Henderson JA; Howard WJ; Lee ET; Mete M; Poolaw B; Ratner RE; Russell M; Silverman A; Stylianou M; Umans JG; Wang W; Weir MR; Weissman NJ; Wilson C; Yeh F; Zhu J
JAMA; 2008 Apr; 299(14):1678-89. PubMed ID: 18398080
[TBL] [Abstract][Full Text] [Related]
3. Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.
Fleg JL; Mete M; Howard BV; Umans JG; Roman MJ; Ratner RE; Silverman A; Galloway JM; Henderson JA; Weir MR; Wilson C; Stylianou M; Howard WJ
J Am Coll Cardiol; 2008 Dec; 52(25):2198-205. PubMed ID: 19095139
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) .
Wilson C; Huang CC; Shara N; Howard BV; Fleg JL; Henderson JA; Howard WJ; Huentelman H; Lee ET; Mete M; Russell M; Galloway JM; Silverman A; Stylianou M; Umans J; Weir MR; Yeh F; Ratner RE
J Clin Lipidol; 2010; 4(3):165-72. PubMed ID: 20563294
[TBL] [Abstract][Full Text] [Related]
5. Relationship of glycemia control to lipid and blood pressure lowering and atherosclerosis: the SANDS experience.
Mete M; Wilson C; Lee ET; Silverman A; Russell M; Stylianou M; Umans JG; Wang W; Howard WJ; Ratner RE; Howard BV; Fleg JL
J Diabetes Complications; 2011; 25(6):362-7. PubMed ID: 21775166
[TBL] [Abstract][Full Text] [Related]
6. Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS).
Russell M; Fleg JL; Galloway WJ; Henderson JA; Howard J; Lee ET; Poolaw B; Ratner RE; Roman MJ; Silverman A; Stylianou M; Weir MR; Wilson C; Yeh F; Zhu J; Howard BV
Am Heart J; 2006 Nov; 152(5):867-75. PubMed ID: 17070147
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study.
Ludwig M; Stapff M; Ribeiro A; Fritschka E; Tholl U; Smith RD; Stumpe KO
Clin Ther; 2002 Jul; 24(7):1175-93. PubMed ID: 12182261
[TBL] [Abstract][Full Text] [Related]
8. Achieving lipid targets in adults with type 2 diabetes: the Stop Atherosclerosis in Native Diabetics Study.
Russell M; Silverman A; Fleg JL; Lee ET; Mete M; Weir M; Wilson C; Yeh F; Howard BV; Howard WM
J Clin Lipidol; 2010; 4(5):435-43. PubMed ID: 21076630
[TBL] [Abstract][Full Text] [Related]
9. Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trial.
Weir MR; Yeh F; Silverman A; Devereux RB; Galloway JM; Henderson JA; Howard WJ; Russell M; Wilson C; Ratner R; Sorkin J; Umans JG; Fleg JL; Stylianou M; Lee E; Howard BV
J Clin Hypertens (Greenwich); 2009 Oct; 11(10):540-8. PubMed ID: 19817934
[TBL] [Abstract][Full Text] [Related]
10. Increased arterial stiffness in familial combined hyperlipidemia.
Brouwers MC; Reesink KD; van Greevenbroek MM; Meinders JM; van der Kallen CJ; Schaper N; Hoeks AP; Stehouwer CD
J Hypertens; 2009 May; 27(5):1009-16. PubMed ID: 19402225
[TBL] [Abstract][Full Text] [Related]
11. Effect of antihypertensive therapy on progression of carotid intima-media thickness in patients with type 2 diabetes mellitus.
Zheng L; Hodis HN; Buchanan TA; Li Y; Mack WJ
Am J Cardiol; 2007 Apr; 99(7):956-60. PubMed ID: 17398191
[TBL] [Abstract][Full Text] [Related]
12. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
[TBL] [Abstract][Full Text] [Related]
13. Adherence to prescription guidelines and achievement of treatment goals among persons with coronary heart disease in Tromsø 7.
Pedersen E; Garcia BH; Halvorsen KH; Eggen AE; Schirmer H; Waaseth M
BMC Cardiovasc Disord; 2021 Jan; 21(1):44. PubMed ID: 33478404
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome less strongly associated with target organ damage than syndrome components in a healthy, working population.
Eguchi K; Schwartz JE; Roman MJ; Devereux RB; Gerin W; Pickering TG
J Clin Hypertens (Greenwich); 2007 May; 9(5):337-44. PubMed ID: 17485969
[TBL] [Abstract][Full Text] [Related]
15. Hypotensive, hypolipidemic, and vascular protective effects of Morus alba L. in rats fed an atherogenic diet.
Lee YJ; Choi DH; Kim EJ; Kim HY; Kwon TO; Kang DG; Lee HS
Am J Chin Med; 2011; 39(1):39-52. PubMed ID: 21213397
[TBL] [Abstract][Full Text] [Related]
16. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study.
Mörtsell D; Malmqvist K; Held C; Kahan T
J Intern Med; 2007 May; 261(5):472-9. PubMed ID: 17444886
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia.
Ge CJ; Lu SZ; Chen YD; Wu XF; Hu SJ; Ji Y
Heart Vessels; 2008 Mar; 23(2):91-5. PubMed ID: 18389332
[TBL] [Abstract][Full Text] [Related]
18. Early detection of atherosclerosis in type 2 diabetic patients by endothelial dysfunction and intima-media thickness.
Ifrim S; Vasilescu R
Rom J Intern Med; 2004; 42(2):343-54. PubMed ID: 15529625
[TBL] [Abstract][Full Text] [Related]
19. [Trends in subclinical atherosclerosis in patients with arterial hypertension associated with diabetes mellitus: a relationship between blood pressure achieved with antihypertensive therapy and body weight].
Karpov RS; Koshel'skaia OA; Khoroshilova IV
Ter Arkh; 2010; 82(9):23-30. PubMed ID: 21086616
[TBL] [Abstract][Full Text] [Related]
20. Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study.
Lee JM; Robson MD; Yu LM; Shirodaria CC; Cunnington C; Kylintireas I; Digby JE; Bannister T; Handa A; Wiesmann F; Durrington PN; Channon KM; Neubauer S; Choudhury RP
J Am Coll Cardiol; 2009 Nov; 54(19):1787-94. PubMed ID: 19874992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]